Clinical Trial Update: Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update notes the termination of a Phase 2/Phase 3 study comparing capecitabine (Xeloda) with vinorelbine in women with metastatic breast can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Navelbine (vinorelbine)
• Xeloda (capecitabine)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: TERMINATED